Philanthropic Opportunities
The Sohn Foundation brings together leaders from the worlds of finance, business, and philanthropy to drive meaningful impact and support groundbreaking initiatives in pediatric cancer research and healthcare innovation.
Your contribution can include a range of attractive benefits.
Brand recognition on all conference day print materials or virtual event platform.
Logo listing on the Sohn New York webpage for one year and in all conference communications.
On-stage recognition during live programming.
Opportunity to donate your brand’s product to our guests or speakers.
Sohn Foundation Initiatives
Memorial Sloan Kettering Cancer Center
The Sohn Conference Foundation proudly supports MSK Kids at Memorial Sloan Kettering Cancer Center, one of the nation’s leading pediatric cancer programs dedicated to advancing groundbreaking research and compassionate care for children, teens, and young adults facing cancer and blood disorders.
MSK Kids combines world-class physicians, pioneering clinical trials, and precision medicine approaches to develop more effective and less toxic treatments for childhood cancers. Scientists and researchers at MSK Kids are currently conducting more than 100 clinical trials aimed at improving outcomes and creating new hope for families around the world.
As one of the largest pediatric cancer programs in the United States, MSK Kids treats children with some of the rarest and most complex cancers, while continuing to lead innovations in immunotherapy, genetic testing, and targeted treatments that are shaping the future of pediatric oncology.
The Rockefeller University
The Sohn Conference Foundation has funded Rockefeller’s acquisition of a high-performance supercomputer, equipment pivotal to scientists at the frontlines of discovery. In 2020 and 2021, Sohn also helped fund novel monoclonal antibody therapy for COVID-19.
Artworks
Creative and performing arts programs for children and young adults, serving 35 hospitals in the New York Metropolitan area.
Columbia University Medical Center
The only initiative of its kind, The Sohn Precision Medicine Program at Columbia UMC ensures all high-risk pediatric cancer patients from NYC have access to precision medicine via Columbia’s advanced diagnostic genomic testing.
NYU Langone
Funding for a brain diagnostic tumor program available at no other institution, with an emphasis on ensuring its availability for NYC children; plus, funding for a brand new children’s hospital, with special rooms for children with cancer.
Damon Runyon Cancer Research Foundation
The Damon Runyon-Sohn Pediatric Cancer Fellowship Award funds basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers.
Mount Sinair Kravis Children's Hospital
The Lion’s Den provides a safe and technology-enabled center for children and teenagers being treated for cancer.
New York Genome Center
The Sohn Collaborative Research Project for Pediatric Cancer brings together elite researchers from Columbia University, Memorial Sloan Kettering, NYU Langone, Rockefeller University, and Weill Cornell to tackle unanswered questions about the genomics of pediatric cancer.
Pershing Square Cancer Research
Provides top New York-based scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking.
Weill Cornell Medicine
Funding to provide state-of-the-art research equipment to examine cancer metastasis and potential targets for new therapies.
Hackensack University Medical Center
The Sohn-Manning Pediatric Cancer Survivorship Program at HackensackUMC launched in 2016. The Children’s Cancer Institute at HackensackUMC focuses on the long term emotional and social issues specific to pediatric cancer survivors, as well as finding a cure with more than 100 active clinical trials. Sohn recognizes Eli Manning's leadership in helping HackensackUMC tackle kids cancer from all angles.
New York Presbyterian
Provided seed funding for the complete renovation of the Pediatric Infusion Center for outpatients to receive treatment in a space specially designed for children.
Tri-Institutional Therapeutics Discovery Institute
Funding for collaborative research into leukemia and melanoma conducted within the unique drug discovery consortium of Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College.
Board of Directors
Graham Duncan
Chairman & CEO
Daniel Nir
Co-Founder & President
Evan Sohn
Co-Founder & Vice President
Douglas Hirsch
Co-Founder & Chair Emeritus
With gratitude and appreciation, The Foundation recognizes Douglas Hirsch’s founding of The Sohn Conference Foundation and 24 years of service.
In Memory of Ira
The Foundation honors the memory of Ira Sohn, a talented Wall Street professional whose life was cut short when he passed away from cancer at the age of 29. In 1995, Ira’s friends Douglas Hirsch, Lance Laifer and Daniel Nir, along with Ira’s mother Judith Sohn and brother Evan, created The Sohn Conference Foundation.